Experimental investigation of proangiogenic properties of sacubitril on a chorio allantoic membrane model
| dc.authorid | 0000-0003-3432-4946 | |
| dc.contributor.author | Ozgul, Mustafa | |
| dc.contributor.author | Aydogan, Eyup | |
| dc.date.accessioned | 2026-01-24T12:29:09Z | |
| dc.date.available | 2026-01-24T12:29:09Z | |
| dc.date.issued | 2025 | |
| dc.department | Alanya Alaaddin Keykubat Üniversitesi | |
| dc.description.abstract | Background: Sacubitril is an important and effective agent for cardiovascular remodeling. This study aims to evaluate its proangiogenic effects in an experimental model. Methods: The chorioallantoic membrane (CAM) model was created for the investigation of the proangiogenic potential of sacubitril with different therapeutic doses (10(-7) M, 10(-6) M, 10(-5) M) and compared with drug-free pellet group (sham) and normal morphology (control) of chick embryo development in drug-free chick embryos. The developing embryo's vascularity and the pellets' effect were evaluated under a stereoscopic microscope. The density of vascular shoots and newly formed vascular nodules were not recorded. Results: There was no significant difference between the control and drug-free pellet groups (12.4 +/- 2.8 vs. 14.1 +/- 1.3 junctions per ROI, p = 0.48). The incremental angiogenic properties were detected in drug groups as follows: 15.3 +/- 3.8 per ROI in Group I (10(-7) M concentration); 21.6 +/- 5.4 per ROI in Group II (10(-6) M concentration); 22.9 +/- 8.1 per ROI in Group III (10(-5) M concentration) (p < 0.001). Conclusion: Our findings support that sacubitril provokes angiogenesis in a dose-dependent manner. Investigating these properties can be useful for understanding further effects of this agent in other cardiovascular diseases. Therapeutic angiogenesis is important for ameliorating the results. | |
| dc.identifier.doi | 10.1177/13860291251352350 | |
| dc.identifier.endpage | 121 | |
| dc.identifier.issn | 1386-0291 | |
| dc.identifier.issn | 1875-8622 | |
| dc.identifier.issue | 3 | |
| dc.identifier.pmid | 40624986 | |
| dc.identifier.scopus | 2-s2.0-105014130065 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 116 | |
| dc.identifier.uri | https://doi.org/10.1177/13860291251352350 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12868/5140 | |
| dc.identifier.volume | 90 | |
| dc.identifier.wos | WOS:001524180600001 | |
| dc.identifier.wosquality | N/A | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Sage Publications Inc | |
| dc.relation.ispartof | Clinical Hemorheology and Microcirculation | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20260121 | |
| dc.subject | Sacubitril | |
| dc.subject | angiogenesis | |
| dc.subject | CAM model | |
| dc.subject | remodeling | |
| dc.title | Experimental investigation of proangiogenic properties of sacubitril on a chorio allantoic membrane model | |
| dc.type | Article |












